Clinical trial for Alcohol Use Disorder
Official title Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder
ClinicalTrials.gov ID: NCT06415721
What this study is testing
- What it's testing
- This study is testing whether a single TMS session guided by fMRI can lower brain reactivity to alcohol cues in people with alcohol use disorder.
- Who it's for
- You may be able to join if you have alcohol use disorder and are looking for new treatments.
- What's involved
- You will have a brain scan to find the best spot, then receive one TMS session. You may also have follow‑up visits to check brain activity.
- Time commitment
- The study lasts about a week, with a scan, a TMS session, and a follow‑up visit.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 75
You may be able to join if
- Between age 25 and 75.
- Current DSM-5 diagnosis of moderate to severe AUD (≥4 diagnostic symptoms).
- Able to attend scheduled clinic visits
- Able to read, understand and voluntarily sign Informed Consent prior to participating in any study-specific procedures or assessments.
- If on a medication regimen, that regimen will be stable for the duration of the study;
You likely can't join if
- Transcranial magnetic stimulation (TMS) and magnetic resonance imaging (MRI) contraindications: such as a cardiac pacemaker, cochlear implant, or an...
- General medical condition, disease or neurological disorder that interferes with the assessments or participation.
- Unable to safely withdraw, at least two weeks prior to treatment, from medications that increase seizure risk.
- Current substance abuse (except caffeine or nicotine) as determined by positive toxicology screen.
- Have a mass lesion, cerebral infarct, or other active CNS disease, including an alcohol-related seizure or a seizure disorder.
- Severe impediment to vision, hearing and/or hand movement, likely to interfere with the ability to follow study protocols.
See the full eligibility criteria
- Between age 25 and 75.
- Current DSM-5 diagnosis of moderate to severe AUD (≥4 diagnostic symptoms).
- Able to attend scheduled clinic visits
- Able to read, understand and voluntarily sign Informed Consent prior to participating in any study-specific procedures or assessments.
- If on a medication regimen, that regimen will be stable for the duration of the study;
- Fluency in English.
- Transcranial magnetic stimulation (TMS) and magnetic resonance imaging (MRI) contraindications: such as a cardiac pacemaker, cochlear implant, or an implanted device (deep brain stimulation, metal in the head, metal in...
- General medical condition, disease or neurological disorder that interferes with the assessments or participation.
- Unable to safely withdraw, at least two weeks prior to treatment, from medications that increase seizure risk.
- Current substance abuse (except caffeine or nicotine) as determined by positive toxicology screen.
- Have a mass lesion, cerebral infarct, or other active CNS disease, including an alcohol-related seizure or a seizure disorder.
- Severe impediment to vision, hearing and/or hand movement, likely to interfere with the ability to follow study protocols.
- Taking benzodiazepine or neuroleptic medications, or any medication known to alter seizure threshold
- unstable chronic illness.
- Current or lifetime history of bipolar disorder or psychosis.
- Participation in another concurrent intervention based clinical trial.
The study team makes the final eligibility decision.
Where it is enrolling
- Palo Alto, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 25 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Palo Alto, California, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.